Zulresso
Drug Psychiatrypsychology
NDC 72152-547-20
General payments
$361,226
Research payments
$2,718,814
Through program year 2022, $361,226 in general payments and $2,718,814 in research payments were reported against Zulresso (Psychiatrypsychology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $44,443 | 1,321 |
| 2022 | Research | $556,666 | 46 |
| 2021 | General | $57,618 | 804 |
| 2021 | Research | $1,219,789 | 97 |
| 2020 | General | $259,164 | 494 |
| 2020 | Research | $942,359 | 54 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 45 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 35 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
2,619 general · 197 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.